• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Stock

Musk’s brain implant company filed as a ‘disadvantaged business’

by July 19, 2025
written by July 19, 2025

Elon Musk’s health tech company Neuralink labeled itself a “small disadvantaged business” in a federal filing with the U.S. Small Business Administration, shortly before a financing round valued the company at $9 billion.

Neuralink is developing a brain-computer interface (BCI) system, with an initial aim to help people with severe paralysis regain some independence. BCI technology broadly can translate a person’s brain signals into commands that allow them to manipulate external technologies just by thinking.

Neuralink’s filing, dated April 24, would have reached the SBA at a time when Musk was leading the Trump administration’s Department of Government Efficiency. At DOGE, Musk worked to slash the size of federal agencies.

MuskWatch first reported on the details of Neuralink’s April filing.

According to the SBA’s website, a designation of SDB means a company is at least 51% owned and controlled by one or more “disadvantaged” persons who must be “socially disadvantaged and economically disadvantaged.” An SDB designation can also help a business “gain preferential access to federal procurement opportunities,” the SBA website says.

The Department of Justice has previously fined companies for making false claims about their SDB status.

Musk, the world’s wealthiest person, is CEO of Tesla and SpaceX, in addition to his other businesses like artificial intelligence startup xAI and tunneling venture The Boring Company. In 2022, Musk led the $44 billion purchase of Twitter, which he later named X before merging it with xAI.

Jared Birchall, a Neuralink executive, was listed as the contact person on the filing from April. Birchall, who also manages Musk’s money as head of his family office, didn’t immediately respond to a request for comment.

Neuralink, which incorporated in Nevada, closed a $650 million funding round in early June at a $9 billion valuation. ARK Invest, Peter Thiel’s Founders Fund, Sequoia Capital and Thrive Capital were among the investors. Neuralink said the fresh capital would help the company bring its technology to more patients and develop new devices that “deepen the connection between biological and artificial intelligence.”

Under Musk’s leadership at DOGE, the initiative took aim at government agencies that emphasized diversity, equity and inclusion (DEI). In February, for example, DOGE and Musk boasted of nixing hundreds of millions of dollars worth of funding for the Department of Education that would have gone towards DEI-related training grants.

This post appeared first on NBC NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump has now been in office for six months, for the second time. Here are the highlights
next post
‘Get a job’: Medicaid work requirements included in Trump’s megabill sparks partisan debate on Capitol Hill

related articles

Airbus says most of its recalled 6,000 A320...

December 2, 2025

Campbell’s fires executive accused of racist remarks and...

November 28, 2025

Bitcoin and other crypto assets sink in flight...

November 24, 2025

Stock market sinks as AI and interest rate...

November 24, 2025

Bargain hunters drive Walmart sales and outlook higher

November 21, 2025

U.S. added 119,000 jobs in September, but there...

November 21, 2025

What AI bubble? Nvidia’s strong earnings signal there’s...

November 21, 2025

Longtime Walmart CEO to step down in January

November 17, 2025

More than 1,000 Starbucks workers strike at 65...

November 15, 2025

October monthly job cuts surged to a 22-year...

November 7, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Agenus stock plummets over 50% as FDA rejects accelerated approval for BOT/BAL cancer therapy

    July 18, 2024
  • Venezuelan President Nicolas Maduro claims election victory, refuses to publish results

    July 30, 2024
  • Kash Patel flips script on Dem senator after being grilled on J6 pardons: ‘Brutal reality check’

    January 30, 2025
  • Stellantis share price has collapsed: death cross points to more pain

    March 6, 2025
  • Status price: are spot Ethereum ETFs bullish for SNT?

    July 23, 2024

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024

Categories

  • Economy (829)
  • Editor's Pick (6,938)
  • Investing (634)
  • Stock (958)

Latest Posts

  • Trump’s final Cabinet pick, Mike Waltz, confirmed by Senate in narrow vote

    September 19, 2025
  • ‘The mission was accomplished’: Senate Republicans push back against leaked report on Iran strikes

    June 26, 2025
  • Blinken warns Israel ‘should not lead a protracted campaign’ against Hezbollah in Lebanon

    October 24, 2024

Recent Posts

  • Zelenskyy agrees to tentative Trump minerals deal, plans to visit DC later this week: report

    February 25, 2025
  • House GOP charts roadmap to ‘Make America Healthy Again,’ cites healthcare system impact on ‘national defense’

    January 22, 2025
  • ‘Deliberate abuse of power’: Republicans erupt after bombshell Zuckerberg letter on COVID-19 censorship

    August 28, 2024

Editor’s Pick

  • ‘Coming for us’: Expert sounds alarm on CCP’s mission to ‘kill Americans’ after FBI makes shocking arrests

    June 5, 2025
  • Trump’s AG pick has ‘history of consensus building’

    November 27, 2024
  • Trump’s Fed Criticism Sparks Investor Concerns

    April 22, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock